← Back to headlines
Mizuho Maintains Outperform Rating on Insmed Incorporated
Mizuho Securities has reiterated its 'Outperform' rating for Insmed Incorporated (INSM), signaling continued confidence in the pharmaceutical company's stock performance.
28 Jun, 20:07 — 28 Jun, 20:07
Sources
Showing 1 of 1 sources
